Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.
第一作者:
I,Dicembrini
第一单位:
Diabetology, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 32, 50139, Florence, Italy.
作者:
医学主题词
抗胆固醇血症药(Anticholesteremic Agents);心血管疾病(Cardiovascular Diseases);胆固醇, LDL(Cholesterol, LDL);人类(Humans);年患病率(Morbidity);预后(Prognosis);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率(Survival Rate)
DOI
10.1007/s40618-019-01019-4
PMID
30762200
发布时间
2022-04-09
- 浏览6
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



